Cannabis Law Report

FEBRUARY 10, 2023

Canada’s Globe & Mail reports on their court case A years-long access-to-information battle between journalists and Health Canada over data on the locations of large-scale medical cannabis growers has concluded with a Federal Court judge ruling that even city or town information could risk identifying patients and is therefore protected from (..)

Data 52

Data Access Patients Cannabis 52

Cannabis Law Report

AUGUST 8, 2021

A new poll, commissioned by the Canadian Psychedelic Association, has highlighted widespread support for legal access to psilocybin-assisted therapy among Canadians. The Canadian Psychedelic Association (CPA) has today released data from a telephone survey of over 1,000 Canadian adults. Read more at [link].

Therapy 105

Therapy Access Legalization Education 105

NORML

APRIL 30, 2020

The call for comments, posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”

Chronic Pain 339

Chronic Pain Clinical Trials Data Patients 339

Veriheal

DECEMBER 14, 2021

In accordance with this, a new study found that states with legal cannabis markets have been less likely to experience incidences of EVALI, suggesting that properly regulated vape pens are not the problem. An Analysis of Nationwide EVALI Data. ” The study also discovered impacts from other variances in policies across states.

Data 97

Data Vaping Legalization Consumption 97

The Cannigma

JANUARY 16, 2021

Listen & Subscribe: Finding the right cannabis product can be a daunting task for anyone, let alone a new medical patient without any guidance. “That’s not really available in the cannabis industry,” he explained on the Cannabis Enigma podcast. Produced by Elana Goldberg and Michael Schaeffer Omer-Man.

Data 100

Data Research and Development Patients Strains 100

NORML

MARCH 30, 2020

There is an absence of clinical data supporting the efficacy of CBD as an antiviral agent, according to a systematic literature review published in the journal Cannabis and Cannabinoid Research. However, this data was based solely on preclinical findings. ” — appears online here.

CBD 291

CBD Clinical Trials Data Treatment 291

Cannabis Law Report

DECEMBER 8, 2021

Access to headline, upfront, milestone and royalty data. Access to hundreds of Psychiatry deal contract documents. Comprehensive access to over 780 Psychiatry deal records. Access Psychiatry deal headline, upfront, milestone and royalty data. Aurora Cannabis. Analysis of Psychiatry deal structure.

Access 52

Access Data Pharmaceutical Research and Development 52

NORML

JUNE 10, 2019

Military veterans who participate in a state’s medical marijuana access program frequently report substituting cannabis for alcohol and other controlled substances, according to data published in The American Journal of Drug and Alcohol Abuse.

Chronic Pain 263

Chronic Pain Access Collective Medicine 263

SpeedWeed

MARCH 14, 2021

Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Today, databases, predictive analytics, artificial intelligence , and machine learning are having widespread effects on cannabis businesses, investors, regulators, and consumers. Reduce costs.

Data 52

Data Research and Development Marijuana Collective 52

Cannabis Law Report

AUGUST 23, 2022

A panel of Commonwealth Court judges has ordered the Wolf administration to reveal how many medical marijuana patients have received approval from a doctor to use cannabis for opioid addiction treatment. For more than a year, the Department of Health has fought to keep that information secret.

Data 52

Data Treatment Patients Chronic Pain 52

Cannabis Law Report

DECEMBER 11, 2021

The UK’s first and highest-rated medical cannabis clinic, Sapphire Medical Clinics , has today announced that it is reducing the cost of its consultations and appointments for patients enrolled through the Sapphire Access Scheme. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.

Access 52

Access Patients Chronic Pain Treatment 52

Cannabis Law Report

NOVEMBER 16, 2021

First-of-its-kind report confirms cannabis culture is now mainstream and consumer behavior is evolving. This report shares current data and insights indicative of the marketplace, cannabis industry trends, cultural revelations, and the persistent questions at the center of the cannabis conversation in America today.

Data 52

Data Business Retail Dispensary 52

NORML

AUGUST 20, 2019

The self-reported use of marijuana by teenagers continues to decline nationally, according to federal data reported by the United States Substance Abuse and Mental Health Services Administration (SAMHSA). By contrast, self-reported cannabis use by older Americans has risen during this same time period. percent to 12.5 percent to 12.5

Marijuana 211

Marijuana Data Access Environment 211

NORML

JUNE 10, 2020

The agency’s call for comments, initially posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”

Chronic Pain 239

Chronic Pain Therapy Patients Topical 239

Cannabis Law Report

JANUARY 23, 2020

Click on image to access THSuite website. Report: Cannabis Users’ Sensitive Data Exposed in Data Breach. Led by internet privacy researchers Noam Rotem and Ran Locar, vpnMentor’s research team discovered a data breach in THSuite, a point-of-sale system in the cannabis industry. THSuite Company Profile.

Data 59

Data Dispensary Patients Medicine 59

Medicinal Marijuana Association

FEBRUARY 10, 2024

With over 100 known cannabinoids in cannabis, staying informed about the latest research is crucial for making informed decisions. But where do you begin when it comes to navigating the ever-evolving landscape of cannabis studies? Key Takeaways Stay updated with reliable sources to understand latest cannabis research.

Research and Development 52

Research and Development Data Chronic Pain Conditions 52

NORML

JANUARY 31, 2019

Seventy-five percent of military veterans say that they would consider using either “cannabis or cannabinoid products as a treatment option,” according to member survey data compiled by the group Iraq and Afghanistan Veterans of America (IAVA). The organization represents over 400,000 veterans nationwide.

Clinical Trials 188

Clinical Trials Chronic Pain Data Treatment 188

NORML

AUGUST 29, 2019

Remarks made today by the United States Surgeon General highlighting “the importance of protecting our nation from the health risks of marijuana use in adolescents and during pregnancy” fail to acknowledge the role that a regulated market can play in mitigating the use of cannabis by potentially high-risk populations.

Education 223

Education Data Retail Environment 223

Cannabis Law Report

JANUARY 20, 2023

When Oregon voters passed Measure 109 in 2020, to create a legal framework for access to psilocybin services, the ballot initiative explicitly prevented the government from collecting that sensitive personal information without consent. […]

Data 52

Data Patients Legislation Collective 52

NORML

FEBRUARY 1, 2019

Patients authorized to legally use medical cannabis frequently substitute it in place of benzodiazepines, according to a pair of new studies published this week. According to data compiled by the US Centers for Disease Control, the drug was attributed to over 11,500 overdose deaths in 2017.

Patients 239

Patients Chronic Pain Therapy Data 239

NORML

NOVEMBER 25, 2019

Patients suffering from persistent pain conditions who frequently use cannabis are far less likely to use non-prescription opioids, according to longitudinal data published in the journal PLOS One. Authors reported “an independent negative association between frequent cannabis use and frequent illicit opioid use.”

Chronic Pain 277

Chronic Pain Patients Therapy Data 277

Cannabis Law Report

AUGUST 14, 2019

Let’s take a closer look at five key ways big data and technology are directly impacting the industry. Big Data Streamlines the Marijuana Regulatory Process and Helps Close the Scientific Research Gap. Therefore, the growing marijuana market lacks the clinical data needed to help marijuana businesses create new and better products.

Data 45

Data Research and Development Marijuana Collective 45

Cannabis Law Report

NOVEMBER 26, 2021

BRAMPTON, Ontario–(BUSINESS WIRE)–DATA Communications Management Corp. A live webcast of the event will be accessible through the link below. ABOUT DATA COMMUNICATIONS MANAGEMENT CORP. Additional information relating to DATA Communications Management Corp. DATA Communications Management Corp.

Data 52

Data Events Business Retail 52

Americans for Safe Access

MARCH 24, 2020

With everything happening in the news lately, we want to present some scientific data to help medical cannabis patients and adult-use consumers make informed decisions in regard to cannabis products available, product safety, and personal health.

Cannabinoids 241

Cannabinoids Data Safety Patients 241

Veriheal

DECEMBER 14, 2023

There is a persistent and common belief throughout society that using cannabis over an extended period of time (or, in some cases, even once) can lead to a decline in mental abilities and function. The results were pleasing – researchers found no significant difference in cognitive ability before and after participants consumed cannabis.

Chronic Pain 120

Chronic Pain Consumption Cannabis Marijuana 120

MMJ Recs

MAY 3, 2024

With its program in full swing, thousands of patients across the state are benefiting from access to this alternative form of treatment. The program’s success depends not only on initial access but also on sustained, continued access to treatment. Patients can typically submit their applications online with MMJ Recs.

Marijuana 52

Marijuana Treatment Compliance Compliance 52

Veriheal

APRIL 11, 2024

Medical cannabis is more popular than ever before, with 38 states having legalized some form of it for various health conditions. This data aligns with Americans’ rising acceptance of cannabis. The analysis was prompted by the ongoing discussions regarding cannabis rescheduling , which could happen as soon as this year.

Patients 96

Patients Chronic Pain Marijuana Conditions 96

Cannabis Law Report

JULY 21, 2021

Akerna (Nasdaq: KERN ), an enterprise software, leading compliance technology provider, and developer of the cannabis industry’s first seed-to-sale enterprise resource planning (ERP) software technology (MJ Platform®) today announced the release of its second annual mid-year review. You can access the report here. About Akerna.

Supply Chain 105

Supply Chain Seed-To-Sale Data Research and Development 105

NORML

MAY 26, 2020

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Additional information regarding cannabinoids and pain appears online h ere.

Clinical Trials 246

Clinical Trials Chronic Pain Cannabinoids Patients 246

Cannabis Law Report

AUGUST 23, 2021

The TGA recently released a new medical cannabis dashboard detailing a variety of information on both SAS-A and SAS-B approvals. Since launching the SAS-B approval pathway, the TGA has processed more than 148,000 applications to access one of the many medical cannabis products available. Pondering Pot has the story.

Chronic Pain 105

Chronic Pain Concentrates Conditions Data 105

Cannabis Law Report

AUGUST 27, 2021

8, Webinar: Moving from Leaf to new Central Cannabis Reporting System (CCRS). Cannabis licensees, testing labs, and third-party system integrators are invited to attend a webinar on the new CCRS system that will soon replace much of the reporting currently accomplished through the Leaf Data System. until 12:00 p.m.

Data 105

Data Sleep Access Compliance 105

Canna Law Blog

FEBRUARY 10, 2023

We regularly cover litigation on the blog, but today we’re going to cover how to prepare for cannabis litigation that may or may not come. When a lawsuit is filed or – is even reasonably anticipated – the rules of civil procedure in both federal and state courts impose a burden to preserve all potentially relevant records and information.

Data 75

Data Cannabis Access Business 75

Cannabis Chronicles

MAY 22, 2019

“We’ll hand them an iPad, and ask them to fill out a couple quick surveys,” said Michael McDonell, chair of WSU’s Collaboration on Cannabis Policy, Research and Outreach. Some of the outcomes we’re interested in looking at, is what kind of cannabis are they using? The tribe is scheduled to fund the research project for a year.

Medicine 140

Medicine Research and Development Data Collective 140

Illinois News Joint

MAY 16, 2023

Illinois is set to switch its cannabis seed-to-sale tracking system after delivering a Notice of Intent to award a contract to a new vendor. Metrc stated, “Seamless data tracking in Metrc helps operators optimize inventory control, accurately report sales data, and improve cultivation management. including Washington, D.C.,

Seed-To-Sale 67

Seed-To-Sale Supply Chain Data Compliance 67

Cannabis Law Report

JULY 26, 2019

Snohomish, WA — 7/24/2019 — Facebook, Cambridge Analytica, Google+… the list of data sharing scandals is long and filled with multi-million-dollar corporations. 420A3 decided to forego the “traditional revenue stream” that includes sharing/selling their data. How do these other companies get all this data? .

Data 40

Data Policy Collective Consumption 40

Cannabis Law Report

OCTOBER 10, 2019

They have data and reports in play and we presume have fairly healthy numbers in terms of B to B clients. The space is open as High Times are hobbling along due to their MedMen mismatch, Politico, Forbes et al have good cannabis content but not for the mass market. said New Frontier Data Founder and CEO Giadha Aguirre de Carcer. “Our

Data 40

Data Media Banking Cannabis 40

Veriheal

AUGUST 17, 2022

Cannabis’ impact on health is a subject area rife with misunderstanding and controversy. Recently, a study found that cannabis users are more likely to end up needing emergency care, claiming that “cannabis use is not as benign and safe as some might think.” Cannabis Consumers at the Hospital .

Research and Development 96

Research and Development Topical Data Cannabis 96